4//SEC Filing
BARR PHARMACEUTICALS INC 4
Accession 0001209191-08-067412
CIK 0000010081operating
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 9:53 AM ET
Size
12.7 KB
Accession
0001209191-08-067412
Insider Transaction Report
Form 4
CHEFITZ HAROLD N
Director
Transactions
- Exercise/Conversion
Non-Qualified Stock Options
2008-12-23−10,000→ 0 totalExercise: $48.84From: 2007-11-09Exp: 2016-11-09→ Common Stock (10,000 underlying) - Disposition to Issuer
Common Stock
2008-12-23−26,250→ 0 total - Exercise/Conversion
Non-Qualified Stock Options
2008-12-23−7,500→ 0 totalExercise: $37.87From: 2005-10-28Exp: 2014-10-28→ Common Stock (7,500 underlying)
Footnotes (4)
- [F1]Disposed of pursuant to a merger agreement between Issuer and Teva Pharmaceutical Industries Ltd. in exchange for 16,464 shares of Teva Common Stock having a market value of $41.82 per share on the effective date of the merger and cash in the amount of $1,047,375.
- [F2]These options were assumed by Teva Pharmaceutical Industries Ltd pursuant to a merger agreement between the Issuer and Teva and replaced with options to purchase 11,859 shares of Teva Common Stock for $23.95 per share.
- [F3]These options were assumed by Teva Pharmaceutical Industries Ltd pursuant to a merger agreement between the Issuer and Teva and replaced with options to purchase 15,812 shares of Teva Common Stock for $30.89 per share.
- [F4]These options were assumed by Teva Pharmaceutical Industries Ltd pursuant to a merger agreement between the Issuer and Teva and replaced with options to purchase 15,812 shares of Teva Common Stock for $25.14 per share.
Documents
Issuer
BARR PHARMACEUTICALS INC
CIK 0000010081
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000010081
Filing Metadata
- Form type
- 4
- Filed
- Dec 28, 7:00 PM ET
- Accepted
- Dec 29, 9:53 AM ET
- Size
- 12.7 KB